Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2022-08-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$237.3m
reported value
-30.7% vs Q1 2022
12positions
95.8%in top 10
0 new
9 added
2 reduced
0 sold out
vs Q1 2022
Options: 0 call positions (— notional), 1 put positions ($55.7m notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN ARWR | $42.2m17.78% | Added +151.1k |
| BLUEPRINT MEDICINES CORP BPMC | $36.2m15.25% | Reduced -65.0k |
| MERUS N V MRUS | $33.4m14.09% | Added +215.6k |
| ARVINAS INC ARVN | $32.5m13.69% | Added +76.5k |
| REGENXBIO INC RGNX | $28.8m12.15% | Added +49.0k |
| UNIQURE NV QURE | $18.1m7.63% | Added +70.0k |
| AMRYT PHARMA PLC SPONSORED ADS | $13.0m5.50% | Added +226.7k |
| ARGENX SE ARGX | $9.1m3.83% | Unchanged |
| PIERIS PHARMACEUTICALS INC COM | $7.0m2.94% | Added +27.4k |
| GENMAB A/S GMAB | $7.0m2.94% | Added +47.3k |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $6.0m2.53% | Reduced -893.9k |
| SPERO THERAPEUTICS INC SPRO | $3.9m1.66% | Added +39.7k |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $55.7m750.0k shares | New |
Trades reported as a company insider in Q2 2022
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2022-04-26 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $208.2k39.7k shares |